14 Einträge gefunden

1. EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy

   1. Leichsenring, Jonas
   2. Vladimirova, Valentina
   3. Solbach, Christine
   4. Karn, Thomas
   5. Ataseven, Beyhan
   6. Sinn, Bruno Valentin
   7. Barinoff, Jana

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial

   1. Karn, Thomas
   2. Meissner, Tobias
   3. Weber, Karsten E
   4. Solbach, Christine
   5. Denkert, Carsten
   6. Engels, Knut
   7. Fasching, Peter A

   2020 - Forschungsinformationssystem des UKE
3. Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures.

   1. Karn, Thomas
   2. Pusztai, Lajos
   3. Holtrich, Uwe
   4. Iwamoto, Takayuki
   5. Shiang, Christine Y
   6. Schmidt, Marcus
   7. Müller, Volkmar

   2011 - Forschungsinformationssystem des UKE - frei zugänglich
4. Gene expression profiling of luminal B breast cancers reveals NHERF1 as a new marker of endocrine resistance.

   1. Karn, Thomas
   2. Ruckhäberle, Eugen
   3. Hanker, Lars
   4. Müller, Volkmar
   5. Schmidt, Marcus
   6. Solbach, Christine
   7. Gätje, Regine

   2011 - Forschungsinformationssystem des UKE
5. A clinically relevant gene signature in triple negative and basal-like breast cancer.

   1. Rody, Achim
   2. Karn, Thomas
   3. Liedtke, Cornelia
   4. Pusztai, Lajos
   5. Ruckhaeberle, Eugen
   6. Hanker, Lars
   7. Gaetje, Regine

   2011 - Forschungsinformationssystem des UKE - frei zugänglich
6. Loss of Plexin B1 is highly prognostic in low proliferating ER positive breast cancers--results of a large scale microarray analysis.

   1. Rody, Achim
   2. Karn, Thomas
   3. Ruckhäberle, Eugen
   4. Hanker, Lars
   5. Metzler, Dirk
   6. Müller, Volkmar
   7. Solbach, Christine

   2009 - Forschungsinformationssystem des UKE
7. Pituitary tumor-transforming gene expression is a prognostic marker for tumor recurrence in squamous cell carcinoma of the head and neck.

   1. Solbach, Christine
   2. Roller, Marc
   3. Eckerdt, Frank
   4. Peters, Silke
   5. Knecht, Rainald

   2006 - Forschungsinformationssystem des UKE - frei zugänglich
8. EGFR-antibody-supplemented TPF chemotherapy. Preclinical investigations to a novel approach for head and neck cancer induction treatment.

   1. Knecht, Rainald
   2. Peters, Silke
   3. Hambek, Markus
   4. Solbach, Christine
   5. Baghi, Mehran
   6. Gstöttner, Wolfgang

   2005 - Forschungsinformationssystem des UKE
9. Cancer of the uterine cervix is susceptible to anti-EGF-R antibody EMD 55,900 therapy.

   1. Solbach, Christine
   2. Roller, Marc
   3. Nicolettri, Maria
   4. Budischewski, Kai
   5. Knecht, Rainald
   6. Kaufmann, Manfred

   2005 - Forschungsinformationssystem des UKE
10. Pituitary tumor-transforming gene (PTTG): a novel target for anti-tumor therapy.

    1. Solbach, Christine
    2. Roller, Marc
    3. Peters, Silke
    4. Nicoletti, Maria
    5. Kaufmann, Manfred
    6. Knecht, Rainald

    2005 - Forschungsinformationssystem des UKE
11. EGFR antibody-supplemented TPE-chemotherapy. Preclinical investigations to a novel approach for head and neck cancer induction treatment.

    1. Knecht, Rainald
    2. Peters, Silke
    3. Solbach, Christine
    4. Baghi, Mehran
    5. Gstöttner, Wolfgang
    6. Hambek, Markus

    2003 - Forschungsinformationssystem des UKE
12. Antitumor effect of MAb EMD 55900 depends on EGF-R expression and histopathology.

    1. Solbach, Christine
    2. Sterner-Kock, Anja
    3. Roller, Marc
    4. Schnürch, Hans Georg
    5. Stegmüller, Manfred
    6. Caspar-Bell, Gudrun
    7. Schumm-Draeger, Petra Maria

    2002 - Forschungsinformationssystem des UKE - frei zugänglich
13. Anti-epidermal growth factor receptor-antibody therapy for treatment of breast cancer.

    1. Solbach, Christine
    2. Roller, Marc
    3. Ahr, Andre
    4. Loibl, Sibylle
    5. Nicoletti, Maria
    6. Stegmueller, Manfred
    7. Kreysch, Hans-Georg

    2002 - Forschungsinformationssystem des UKE
14. Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells.

    1. Spänkuch-Schmitt, Birgit
    2. Wolf, Georg
    3. Solbach, Christine
    4. Loibl, Sibylle
    5. Knecht, Rainald
    6. Stegmüller, Manfred
    7. von Minckwitz, Gunter

    2002 - Forschungsinformationssystem des UKE